246 related articles for article (PubMed ID: 25154638)
1. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
[TBL] [Abstract][Full Text] [Related]
2. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection.
Onozawa M; Hashino S; Darmanin S; Okada K; Morita R; Takahata M; Shigematsu A; Kahata K; Kondo T; Tanaka J; Imamura M; Asaka M
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1226-30. PubMed ID: 18940676
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
4. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
5. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
6. [Reactivation of hepatitis B virus after autologous peripheral blood stem cell transplantation in patients with positive hepatitis B surface antibodies].
Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T
Rinsho Ketsueki; 2000 Apr; 41(4):322-8. PubMed ID: 10846463
[TBL] [Abstract][Full Text] [Related]
7. Reverse seroconversion of hepatitis B virus after allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease.
Oshima K; Sato M; Okuda S; Terasako K; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Nakamura I; Yoshida Y; Kanda Y
Hematology; 2009 Apr; 14(2):73-5. PubMed ID: 19298717
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
[TBL] [Abstract][Full Text] [Related]
9. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
10. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
Kempinska A; Kwak EJ; Angel JB
Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B serological changes following allogeneic bone marrow transplantation.
Teh BW; Slavin MA; Szer J; Sasadeusz JJ
Transpl Infect Dis; 2013 Feb; 15(1):98-103. PubMed ID: 22783885
[TBL] [Abstract][Full Text] [Related]
13. Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus.
Park S; Kim K; Kim DH; Jang JH; Kim SJ; Kim WS; Jung CW; Koh KC
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1630-7. PubMed ID: 21565276
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
15. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?
Powis JE; Raboud J; Ostrowski M; Loutfy MR; Kovacs C; Walmsley SL
J Infect Dis; 2012 May; 205(10):1534-8. PubMed ID: 22448009
[TBL] [Abstract][Full Text] [Related]
16. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
[TBL] [Abstract][Full Text] [Related]
17. Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation.
Moal V; Motte A; Vacher-Coponat H; Tamalet C; Berland Y; Colson P
J Clin Virol; 2015 Jul; 68():32-6. PubMed ID: 26071332
[TBL] [Abstract][Full Text] [Related]
18. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
[TBL] [Abstract][Full Text] [Related]
19. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
